INVEX Therapeutics Ltd (IXC) — Defensive Interval Ratio

Latest as of December 2025: 265 days

INVEX Therapeutics Ltd (IXC) has a Defensive Interval Ratio of 265 days as of December 2025. Defensive assets of AU$128.00K (cash AU$-, short-term investments AU$-, receivables AU$128.00K) cover 265 days of daily cash needs of AU$483.53/day. Check INVEX Therapeutics Ltd (IXC) tangible net worth to evaluate the tangible quality of the company's equity base.

Defensive Interval Ratio

265 days
Days of operational coverage

Defensive Assets

AU$128.00K
Cash + ST Investments + Receivables

Daily Cash Need

AU$483.53
Current Liabilities ÷ 365

Current Liabilities

AU$176.49K
AUD

INVEX Therapeutics Ltd Defensive Interval Ratio (2019–2025)

This chart shows how INVEX Therapeutics Ltd's Defensive Interval Ratio has evolved across 7 annual periods from 2019 to 2025. As of December 2025, the ratio stands at 265 days, meaning defensive assets of AU$128.00K can fund 265 days of operations without new revenue. Also explore INVEX Therapeutics Ltd (IXC) equity growth momentum to track the company's year-over-year net asset growth rate.

Annual Defensive Interval Ratio for INVEX Therapeutics Ltd (2019–2025)

The table below presents the year-by-year Defensive Interval Ratio for INVEX Therapeutics Ltd from 2019 to 2025, covering 7 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see IXC stock market capitalisation.

Year DIR (days) Defensive Assets (AUD) Daily Cash Need Cash ST Investments Change (days)
2025 154 days AU$92.79K AU$604.37/day AU$- AU$- ▲ +73 days
2024 80 days AU$94.98K AU$1.18K/day AU$- AU$- ▲ +3 days
2023 77 days AU$333.56K AU$4.31K/day AU$- AU$- ▲ +24 days
2022 53 days AU$145.72K AU$2.75K/day AU$- AU$- ▲ +41 days
2021 12 days AU$21.20K AU$1.80K/day AU$- AU$- ▼ -9 days
2020 21 days AU$116.88K AU$5.52K/day AU$- AU$- ▼ -12 days
2019 33 days AU$85.62K AU$2.56K/day AU$- AU$-
DIR = (Cash + Short-term Investments + Net Receivables) / (Daily Cash Expenses)